Members of the billionaire Sackler family that owns Purdue Pharma are weighing whether to add $1 billion to the OxyContin-maker's faltering opioid settlement bid in an effort to win over holdouts, Bloomberg News reported on Thursday.
The addition would bring the family's total contribution to $5.325 billion to get a handful of U.S. state attorneys general to drop their opposition to Purdue's bankruptcy plan, the report said citing people familiar with the matter.
Purdue did not immediately respond to a request for comment.
